VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer

NCT04813913 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Oncology

Interventions

DRUG: Bevacizumab in combination with chemotherapy based on fluoropyrimidine IV

Sponsor

University Hospital, Rouen